The biosafety protocol registration process involves providing the Institutional Biosafety Committee with a risk assessment and information about physical and biological containment approaches, work and safety practices, and other details about planned activities. This information is captured in the IBC Registration Form. Although the form is lengthy, only the sections that apply to a specific laboratory or project must be completed. If activities will involve recombinant or synthetic nucleic acid (rsNA) molecules, please reference the NIH Guidelines as you fill out the form. Additional resources for identifying risk group levels and appropriate safety precautions are available on the Resources page.
Low-risk rsNA activities may qualify for exemption from the NIH Guidelines requirements. For qualifying exempt activities, a registration form must still be submitted to ensure that the IBC has a record of activities occurring in various campus facilities. However, review and approval by the IBC will not be necessary.
Submit completed IBC Registration Forms to [email protected]. The IBC review process is shown below and further detailed here. The IBC meets monthly or as needed to review registration submissions and updates. If you have questions about the registration process, please contact [email protected] — the IBC Coordinator or Chair will be happy to assist.
The IBC communicates primarily through email. Please be sure that your email client is accepting emails from [email protected].
IBC Review Process Flowchart